Dr. Paul Mulholland is a medical oncologist specializing in brain cancer, serving as a consultant at University College Hospital and the National Hospital for Neurology and Neurosurgery. He chairs the HCA Cancer Care brain and CNS tumor board and holds the position of honorary senior lecturer at University College London. With a focus on genomic profiling, Dr. Mulholland has developed a portfolio of clinical trials for novel brain cancer therapies, driving research and innovation in this critical field.